Hillenbrand Inc. has announced the sale of a 51% stake in its Milacron injection molding and extrusion business to an ...

Bain Capital, a leading private investment firm, today announced a majority investment in the Milacron Injection Molding and Extrusion business (or the "Company"), a globally renowned provider of ...

It’s sometimes said that European VC doesn’t have the firepower to compete with VCs in the U.S., which regularly raise ...

Hitachi Ventures will continue to focus on Series A investments. “That is still the sweet spot,” said partner Gayathri ...

Amid the federal funding uncertainty for health and sciences, local life science leaders say this could be a moment for industry partners, investors and others to step up and support the sector.

Brookfield emerges as the third suitor for Insignia, also offering A$3.07 billion and sparking a three-way bidding war for the Aussie wealth manager. Copyright 2025 Thomson Reuters.

Technology disruption, post-globalization, and shifting profit pools will drive dealmaking in the year ahead as interest ...